Drug pricing and risk sharing agreements
In the recent past some forms of risk sharing agreements have been used in some countries in drug pricing. In this note we present a specific risk sharing agreement on effectiveness and show how such mechanism is going to affect the market in the long run. In particular, we will show how the regulator may create a trade off between expected afficacy and the number of patients to be treated using the pricing formula.
Year of publication: |
2008
|
---|---|
Authors: | Capri, Stefano ; Levaggi, Rosella |
Institutions: | Dipartimento di Economia e Management, Università degli Studi di Brescia |
Saved in:
freely available
Saved in favorites
Similar items by person
-
Delay is not the answer: waiting time in health care & income redistribution
Fossati, Amedeo, (2008)
-
From local to global public goods: how should externalities be represented?
Levaggi, Rosella, (2009)
-
Welfare properties of restrictions to health care services based on cost effectiveness
Levaggi, Laura, (2009)
- More ...